DERM
USDJourney Medical Corporation Common Stock
$9.000+0.590 (7.015%)
Real-time Price
Healthcare
Drug Manufacturers - Specialty & Generic
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$8.410
High
$9.010
Low
$8.260
Volume
0.22M
Company Fundamentals
Market Cap
236.8M
Industry
Drug Manufacturers - Specialty & Generic
Country
United States
Trading Stats
Avg Volume
0.16M
Exchange
NCM
Currency
USD
52-Week Range
Low $3.535Current $9.000High $9.01
Related News
GlobeNewswire
Journey Medical Corporation Reports Combined Emrosi™ (DFD-29) Phase 3 Clinical Trial Efficacy Data Analysis Presented at the 2025 Fall Clinical Dermatology Conference
FDA-approved Emrosi (40 mg Minocycline Hydrochloride Modified-Release Capsules, 10 mg immediate release and 30 mg extended release) is available in the United States for the treatment of inflammatory lesions of rosacea
View more
GlobeNewswire
Journey Medical Corporation to Participate in October 2025 Investor Conferences
SCOTTSDALE, Ariz., Oct. 08, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation ("Journey Medical" or "the Company") (NASDAQ:DERM), a commercial-stage pharmaceutical company primarily focused on selling and marketing
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.